After inflammatory stimuli, the rates of hepatic synthesis of several plasma proteins, the acute-phase proteins (APP), increase dramatically while some others, most notably albumin, decrease substantially (1). Among these APP are a number of glycoproteins that manifest microheterogeneity as a result of structural variations of their glycan chains. Increased plasma levels of APP are often accompanied by changes in the patterns of glycosylation of some of these proteins (2-6), readily detected as changes in relative affinity to lectins such as Con A . While monokines, products of activated mononuclear phagocytes, are known to play a major role in regulation of APP gene expression, leading to increased or decreased synthesis and secretion of plasma proteins (7-10), the mechanisms governing the alterations in glycosylation of APP are not known. It has not been firmly established whether these changes in glycosylation reflect differences occurring within hepatocytes or whether they reflect differential clearance of various glycosylated forms of APP from the circulation . If the former possibility is the case, it is unclear whether a common mediator induces both changes of APP synthesis and changes in their patterns of glycosylation, or whether separate mechanisms are responsible for these alterations . The lack of correlation between changes in concentration and pattern of glycosylation of a, acid glycoprotein in certain clinical states suggests that different mechanisms mediate these changes (5). To study the mechanisms governing both glycosylation and synthesis of APP in a single system, we used the human hepatoma cell line Hep 3B as a model . Volume 166 July 1987 253-258 Materials and Methods
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Preparation of Conditioned Medium (CM). Human monocytes were isolated from heparinized peripheral blood by Ficoll-Hypaque gradient centrifugation followed by attachment to plastic culture dishes (100 mm) for 1 .5 h in RPMI 1640 (Mediatech-Fisher Scientific Co., Springfield, NJ) with 20% FCS (Gibco Laboratories, Grand Island, NY) . Adherent cells (1 .5 x 106/dish) were washed and incubated for 24 h in 5 ml of serumfree RPMI 1640 with dexamethasone (1 AM/ml), insulin (0.02 U/ml), and LPS (20 pg/ml) . As expected, after incubation in the presence of dexamethasone (I1), CM tested by the thymocyte proliferation assay (12) did not show IL-1 activity .
Induction of APP in the Hep 3B Cell Line. After subculture, cells were maintained in
Results
Exposure of Hep 3B cells to varying amounts of CM and to supernatant obtained from the COLO 16 line resulted in dose-dependent reduction in accumulation of albumin and increase of accumulation of aPI and Cp (Table I) . Incubation with IL-1, TNF, and HSF I caused reduction ofalbumin and increase of Cp accumulation, but had no effect on aPI . HSF II and HSF III did not significantly affect accumulation of any of the proteins studied . The changes described were most pronounced after 48 h of incubation (Table II) . AFF-EP revealed three microheterogeneous variants of aPI : one nonreactive and two reactive with Con A, and four variants of Cp: two nonreactive and two reactive with the lectin (Fig . 1) . Incubation of Hep 3B cells with CM and COLO 16 caused increased accumulation of forms of aPI and Cp reactive with Con A compared to controls (p < 0 .001) ( Fig . 1 and Table I ) . These changes were dose ( Fig . 2 ) and time (Table II) synthesis of N-glycosidically linked oligosaccharides, completely inhibited reactivity of both APP with the lectin (results not shown) .
Discussion Several mechanisms could be responsible for the effect of CM on patterns of glycosylation of aPI and Cp. Human aPI and Cp both consist ofone polypeptide chain containing three oligosaccharides attached to three separate asparagine residues by N-glycosyl linkages . Both of these APP exhibit multiple microheterogeneous forms in serum, differing in the composition of their bi-and triantennary heteroglycan structures (15) (16) (17) . Con A binds unsubstituted hydroxyl groups at carbons 3, 4, or 6 of a-linked 2-0-substituted mannose residues, and at least two interacting molecules are required for this binding (18) . Only biantennary structures of aPI and Cp react with the lectin, while triantennary structures do not. Thus, the alterations in glycosylation patterns observed in the present studies may reflect a relative increase of bi-over triantennary structures attached to the polypeptide chain . It is possible that various glycosylating enzymes could be activated or depressed by constituents of CM (19 example, be a decrease in synthesis or activity of the ,B-N-acetylglucosaminyl transferase that converts the biantennary to triantennary oligosaccharides . A second possibility is that other glycosylating enzymes that use the same substrates are activated. Finally, it is possible that different kinetics of intracellular transport or different routing may occur in hepatocytes during the acute phase response, with resulting alteration in glycosylation . It has been suggested (3) that increased rate of protein synthesis and lack of parallel activation of certain transferases may result in increase of attached biantennary structures. This possibility seems to be least likely, as increased synthesis of Cp induced by IL-1, TNF, and HSF I BRIEF DEFINITIVE REPORT 257 in these studies was not accompanied by changes in its glycosylation . In addition,
we observed a time-dependent, diminishing response to induction by CM while the effect on glycosylation pattern of aPI was not affected by time (Table II ) .
These studies demonstrate that changes of APP glycosylation seen in human sera during various inflammatory states can be explained by alterations occurring within hepatocytes, and that these changes are regulated by one or more 
